Skip to main content

Table 2 Total number and proportion of herb users for the different drug categories ( N = 239)

From: The co-use of conventional drugs and herbs among patients in Norwegian general practice: a cross-sectional study

Drugs (ATC group)

Total n(%)

Proportion of co-users

p-valueA

Against gastrointestinal conditions (A01-09)

15 (6)

60%

0.288

Analgesics (M01A, N02B)

55 (23)

58%

0.031 B

Anti-infectives (G01, J01-05)

2 (1)

50%

1.000

Anticoagulants (B01)

88 (37)

36%

0.043 B

Antidepressants (N06)

20 (8)

50%

0.815

Antidiabetics (A10)

23 (10)

52%

0.515

Antihistamines (R06)

25 (10)

32%

0.204

Antihyperlipidemic agents (C10)

81 (34)

47%

0.784

Antihypertensives and diuretics (C02-C03, C07-09)

107 (45)

45%

1.000

Anti-menopausal and anticonceptives (G01-03)

21 (9)

48%

0.823

Antirheumatic (L01, L04, M01-04)

28 (12)

39%

0.550

Antiseizure, triptanes and central stimulating drugs (N02C, N03, N06B)

20 (8)

45%

1.000

Chemotherapeutic drugs (L01-04)

5 (2)

60%

0.660

Dermal drugs (D01-11, C05)

14 (6)

64%

0.171

Drugs against urogenital and prostate disorders (G04)

11 (5)

55%

0.551

Ocular drugs (S01)

9 (4)

44%

1.000

Respiratory drugs (R01-05, 07, H02)

20 (8)

45%

1.000

Sedatives and Antipsychotics (N05)

39 (16)

49%

0.726

Strong analgesics (N02A, N07BC)

3 (1)

33%

1.000

Thyroids and antithyroids (H03)

26 (11)

54%

0.406

Vasodilators and cardiac glycosides (C01)

5 (2)

60%

0.660

Other drugs total

14 (6)

57%

0.413

  1. AP-value for comparison of herbal user or non-user for each drug category, analysed with Pearson Chi-Square or Fisher’s exact test if the number of total users was below five.
  2. BSignificantly different with p < 0.05.